GERON CORP Income (Loss) from Equity Method Investments
GERON CORP (GERN) reported Income (Loss) from Equity Method Investments of $0 for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-07.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2014-03-17
- GERON CORP income (loss) from equity method investments for the quarter ending 2012-03-31 was $0.00.
- GERON CORP income (loss) from equity method investments for the quarter ending 2011-12-31 was $0.00.
- GERON CORP income (loss) from equity method investments for the quarter ending 2011-09-30 was $0.00.
- GERON CORP income (loss) from equity method investments for the quarter ending 2011-06-30 was -$168.00K.
- GERON CORP income (loss) from equity method investments for fiscal 2011 was -$503.00K.
- GERON CORP income (loss) from equity method investments for fiscal 2010 was -$2.35M.
- GERON CORP income (loss) from equity method investments for fiscal 2009 was -$1.34M.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2012-03-31 | $0.00 10-Q · filed 2012-05-07 | $0.00 derived: sum of 2 quarters · filed 2014-03-17 | $0.00 derived: sum of 3 quarters · filed 2014-03-17 | -$168.00K derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $0.00 derived: sum of 2 quarters · filed 2014-03-17 | -$168.00K derived: sum of 3 quarters · filed 2014-03-17 | -$503.00K 10-K · filed 2014-03-17 |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-03 | -$168.00K derived: sum of 2 quarters · filed 2012-08-03 | -$503.00K 10-Q · filed 2012-11-02 | -$1.72M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | -$168.00K 10-Q · filed 2012-08-03 | -$503.00K 10-Q · filed 2012-08-03 | -$1.72M derived: sum of 3 quarters · filed 2013-03-15 | -$1.96M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | -$335.00K 10-Q · filed 2012-05-07 | -$1.55M derived: sum of 2 quarters · filed 2013-03-15 | -$1.79M derived: sum of 3 quarters · filed 2013-03-15 | -$2.29M derived: sum of 4 quarters · filed 2013-03-15 |
| 2010-12-31 | -$1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$1.46M derived: sum of 2 quarters · filed 2013-03-15 | -$1.95M derived: sum of 3 quarters · filed 2013-03-15 | -$2.35M 10-K · filed 2013-03-15 |
| 2010-09-30 | -$243.00K 10-Q · filed 2011-11-03 | -$739.00K derived: sum of 2 quarters · filed 2011-11-03 | -$1.14M 10-Q · filed 2011-11-03 | |
| 2010-06-30 | -$496.00K 10-Q · filed 2011-08-05 | -$892.00K 10-Q · filed 2011-08-05 | ||
| 2009-12-31 | -$1.34M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |